Developing a quality measure to assess use of antibiotic medications for respiratory conditions

Abstract Objective: Antibiotics are essential medications for treating life-threatening infections. However, incorrect prescribing can lead to adverse events and contribute to antibiotic resistance. We sought to develop a utilization quality measure that could be used by health insurance plans to...

Full description

Bibliographic Details
Main Authors: Brandi L. Melville, Taylor Musser, Ezra Fishman, Danielle Rainis, Sepheen C. Byron
Format: Article
Language:English
Published: Cambridge University Press 2023-01-01
Series:Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:https://www.cambridge.org/core/product/identifier/S2732494X2200328X/type/journal_article
_version_ 1827995935792168960
author Brandi L. Melville
Taylor Musser
Ezra Fishman
Danielle Rainis
Sepheen C. Byron
author_facet Brandi L. Melville
Taylor Musser
Ezra Fishman
Danielle Rainis
Sepheen C. Byron
author_sort Brandi L. Melville
collection DOAJ
description Abstract Objective: Antibiotics are essential medications for treating life-threatening infections. However, incorrect prescribing can lead to adverse events and contribute to antibiotic resistance. We sought to develop a utilization quality measure that could be used by health insurance plans to track overall prescribing for respiratory conditions. Design: A consensus-based process that included evidence review, testing, and stakeholder input was used to develop a measure and assess its usefulness for the Healthcare Effectiveness Data and Information Set (HEDIS), a national quality measurement tool. Methods: Guidelines and literature were reviewed to establish the rationale for the measure. The measure was tested in claims data for commercial, Medicaid and Medicare Advantage enrollees to assess feasibility of collecting and reporting needed information. The measure was vetted with multistakeholder advisory panels and posted for public comment to solicit wide input on relevance and usability. Results: Respiratory conditions are frequent reasons for outpatient care in the data assessed. On average, across all lines of business, the measure revealed that approximately one-third of outpatient visits for respiratory conditions are followed by antibiotics. Stakeholders supported the measure as a tool for monitoring antibiotic prescribing across health plans alongside existing measures that assess inappropriate prescribing for specific conditions. The final measure assesses the number of antibiotic prescriptions dispensed across all outpatient respiratory-related encounters at a health-plan level. Conclusions: The measure on antibiotic prescribing for respiratory conditions was relevant, feasible, and useful. Stakeholders strongly supported the newly developed measure and recommended its integration into HEDIS.
first_indexed 2024-04-10T05:04:10Z
format Article
id doaj.art-e2ffd56891f24c64a83a39c0c4b4dbad
institution Directory Open Access Journal
issn 2732-494X
language English
last_indexed 2024-04-10T05:04:10Z
publishDate 2023-01-01
publisher Cambridge University Press
record_format Article
series Antimicrobial Stewardship & Healthcare Epidemiology
spelling doaj.art-e2ffd56891f24c64a83a39c0c4b4dbad2023-03-09T12:27:53ZengCambridge University PressAntimicrobial Stewardship & Healthcare Epidemiology2732-494X2023-01-01310.1017/ash.2022.328Developing a quality measure to assess use of antibiotic medications for respiratory conditionsBrandi L. Melville0https://orcid.org/0000-0003-2761-016XTaylor Musser1https://orcid.org/0000-0002-9886-9614Ezra Fishman2https://orcid.org/0000-0002-5130-6734Danielle Rainis3https://orcid.org/0000-0002-9943-222XSepheen C. Byron4https://orcid.org/0000-0002-4365-0869National Committee for Quality Assurance, Washington, DCNational Committee for Quality Assurance, Washington, DCNational Committee for Quality Assurance, Washington, DCNational Committee for Quality Assurance, Washington, DCNational Committee for Quality Assurance, Washington, DC Abstract Objective: Antibiotics are essential medications for treating life-threatening infections. However, incorrect prescribing can lead to adverse events and contribute to antibiotic resistance. We sought to develop a utilization quality measure that could be used by health insurance plans to track overall prescribing for respiratory conditions. Design: A consensus-based process that included evidence review, testing, and stakeholder input was used to develop a measure and assess its usefulness for the Healthcare Effectiveness Data and Information Set (HEDIS), a national quality measurement tool. Methods: Guidelines and literature were reviewed to establish the rationale for the measure. The measure was tested in claims data for commercial, Medicaid and Medicare Advantage enrollees to assess feasibility of collecting and reporting needed information. The measure was vetted with multistakeholder advisory panels and posted for public comment to solicit wide input on relevance and usability. Results: Respiratory conditions are frequent reasons for outpatient care in the data assessed. On average, across all lines of business, the measure revealed that approximately one-third of outpatient visits for respiratory conditions are followed by antibiotics. Stakeholders supported the measure as a tool for monitoring antibiotic prescribing across health plans alongside existing measures that assess inappropriate prescribing for specific conditions. The final measure assesses the number of antibiotic prescriptions dispensed across all outpatient respiratory-related encounters at a health-plan level. Conclusions: The measure on antibiotic prescribing for respiratory conditions was relevant, feasible, and useful. Stakeholders strongly supported the newly developed measure and recommended its integration into HEDIS. https://www.cambridge.org/core/product/identifier/S2732494X2200328X/type/journal_article
spellingShingle Brandi L. Melville
Taylor Musser
Ezra Fishman
Danielle Rainis
Sepheen C. Byron
Developing a quality measure to assess use of antibiotic medications for respiratory conditions
Antimicrobial Stewardship & Healthcare Epidemiology
title Developing a quality measure to assess use of antibiotic medications for respiratory conditions
title_full Developing a quality measure to assess use of antibiotic medications for respiratory conditions
title_fullStr Developing a quality measure to assess use of antibiotic medications for respiratory conditions
title_full_unstemmed Developing a quality measure to assess use of antibiotic medications for respiratory conditions
title_short Developing a quality measure to assess use of antibiotic medications for respiratory conditions
title_sort developing a quality measure to assess use of antibiotic medications for respiratory conditions
url https://www.cambridge.org/core/product/identifier/S2732494X2200328X/type/journal_article
work_keys_str_mv AT brandilmelville developingaqualitymeasuretoassessuseofantibioticmedicationsforrespiratoryconditions
AT taylormusser developingaqualitymeasuretoassessuseofantibioticmedicationsforrespiratoryconditions
AT ezrafishman developingaqualitymeasuretoassessuseofantibioticmedicationsforrespiratoryconditions
AT daniellerainis developingaqualitymeasuretoassessuseofantibioticmedicationsforrespiratoryconditions
AT sepheencbyron developingaqualitymeasuretoassessuseofantibioticmedicationsforrespiratoryconditions